After hosting a call with CEO Chris Kramer and CFO Bill Roeschlein, Lake Street analyst Jaeson Schmidt has increased confidence that Intermolecular is positioned to see sustained top line growth and improving profitability this year and next. The analyst continues to like how shares are set up for this year saying growth should no longer be "masked" and year-over-year comps get easier in the second half of 2019. Further, with 58% of the market cap in cash and the recently announced $10M buyback program, there should be a "relatively high floor" on Intermolecular shares in the near-term, contends Schmidt. He reiterates a Buy rating on the stock with a $3 price target.